Hyperfine Inc. has announced the launch of the AI-powered eighth generation of Swoop system software. The software’s diffusion-weighted imaging (DWI) AI denoising feature received FDA clearance in October 2023, and it has been rolled out at select sites over the past several weeks through a limited market release. The latest software improves Swoop system image quality and introduces valuable ease-of-use features, including a real-time aid for more precise patient loading and positioning and a streamlined image upload process.
With CE and UKCA certifications for this latest software, Hyperfine Inc. is positioned for future international expansion, bringing the Swoop system to a broader global market.
“Our latest AI-powered software, the eighth generation of our proprietary software platform, embodies our commitment to supporting clinicians in critical decision-making,” remarked Tom Teisseyre Ph.D., chief operating officer of Hyperfine Inc. “Our focus on image quality with this latest software has been on the DWI sequence, which is key in stroke imaging. Since its first FDA clearance in 2020, we’ve been dedicated to continually enhancing image quality and workflow efficiencies to define best-in-class, user-centric, ultra-low field MR brain imaging.”
For more information, visit hyperfine.io.
